The maximum tolerated dose and biologic effects of 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors

Brian S. Choi, Dona B. Alberti, William R. Schelman, Jill M. Kolesar, James P. Thomas, Rebecca Marnocha, Jens C. Eickhoff, S. Percy Ivy, George Wilding, Kyle D. Holen

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'The maximum tolerated dose and biologic effects of 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science